組織バンク市場は、予測期間中に8.5％の健全なCAGRを示すと予想されます。悪性腫瘍、冠動脈疾患、糖尿病感染症などの継続的な疾患の優勢性の高まりが、世界中に大きな影響を与えているだけでなく、継続的な疾患の治療のための最先端の治療オプションへの関心も高まっています。米国悪性増殖協会によると、米国では約 190 万件の新たな疾患の症例が分析されました。さらに、冠状動脈疾患が男女ともに主な死因と考えられています。米国では約 4,66,566 人が冠状動脈疾患を経験しています。冠状動脈疾患による米国のコストは、2018年から2019年にかけて一貫して約2,399億ドルに上っています。したがって、冠状動脈疾患と糖尿病の一般性の高まりによって組織バンキングへの関心が拡大しています。それが組織バンキングの発展を推進します。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. MARKET ATTRACTIVENESS ANALYSIS
1.1.1. GLOBAL TISSUE BANKING MARKET, BY TYPE
1.1.2. GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE
1.1.3. GLOBAL TISSUE BANKING MARKET, BY APPLICATION
1.1.4. GLOBAL TISSUE BANKING MARKET, BY REGION
2. MARKET INTRODUCTION
2.1. DEFINITION
2.2. SCOPE OF THE STUDY
2.3. MARKET STRUCTURE
3. RESEARCH METHODOLOGY
3.1. OVERVIEW
3.2. DATA MINING
3.3. SECONDARY RESEARCH
3.4. PRIMARY RESEARCH
3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
3.5. FORECASTING TECHNIQUE
3.6. MARKET SIZE ESTIMATION
3.6.1. BOTTOM-UP APPROACH
3.6.2. TOP-DOWN APPROACH
3.7. DATA TRIANGULATION
3.8. VALIDATION
4. MARKET DYNAMICS
4.1. INTRODUCTION
4.2. DRIVERS
4.3. RESTRAINTS
4.4. OPPORTUNITIES
5. MARKET FACTOR ANALYSIS
5.1. VALUE CHAIN ANALYSIS
5.2. PORTER’S FIVE FORCES ANALYSIS
5.2.1. BARGAINING POWER OF SUPPLIERS
5.2.2. BARGAINING POWER OF BUYERS
5.2.3. THREAT OF NEW ENTRANTS
5.2.4. THREAT OF SUBSTITUTES
5.2.5. INTENSITY OF RIVALRY
5.3. COVID-19 IMPACT ANALYSIS
5.3.1. MARKET IMPACT ANALYSIS
5.3.2. REGIONAL IMPACT
5.3.3. OPPORTUNITY AND THREAT ANALYSIS
6. GLOBAL TISSUE BANKING MARKET, BY TYPE
6.1. OVERVIEW
6.2. MEDIA AND CONSUMABLE
6.3. CRYOPRESERVATION EQUIPMENT
6.4. THAWING EQUIPMENT
6.5. QUALITY CONTROL EQUIPMENT
6.6. OTHERS
7. GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE
7.1. OVERVIEW
7.2. HEART VALVE
7.3. CORNEA
7.4. BONE
7.5. SKIN
7.6. BRAIN & SPINAL CORD
7.7. OTHERS
8. GLOBAL TISSUE BANKING MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. THERAPEUTICS
8.3. MEDICAL RESEARCH
8.4. OTHERS
9. GLOBAL TISSUE BANKING MARKET, BY REGION
9.1. OVERVIEW
9.2. NORTH AMERICA
9.2.1. US
9.2.2. CANADA
9.3. EUROPE
9.3.1. GERMANY
9.3.2. FRANCE
9.3.3. UK
9.3.4. ITALY
9.3.5. SPAIN
9.3.6. REST OF EUROPE
9.4. ASIA-PACIFIC
9.4.1. CHINA
9.4.2. INDIA
9.4.3. JAPAN
9.4.4. AUSTRALIA
9.4.5. SOUTH KOREA
9.4.6. REST OF ASIA-PACIFIC
9.5. REST OF THE WORLD
9.5.1. MIDDLE EAST
9.5.2. AFRICA
9.5.3. LATIN AMERICA
10. COMPETITIVE LANDSCAPE
10.1. INTRODUCTION
10.2. COMPETITIVE ANALYSIS
10.3. MARKET SHARE ANALYSIS
10.4. MAJOR GROWTH STRATEGY IN THE GLOBAL TISSUE BANKING MARKET
10.5. COMPETITIVE BENCHMARKING
10.6. LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL TISSUE BANKING MARKET
10.7. KEY DEVELOPMENTS & GROWTH STRATEGIES
10.7.1. NEW PRODUCT LAUNCH
10.7.2. MERGER & ACQUISITION
10.7.3. JOINT VENTURES
10.8. MAJOR PLAYERS FINANCIAL MATRIX
10.8.1. SALES & OPERATING INCOME, 2022
10.8.2. MAJOR PLAYERS R&D EXPENDITURE, 2022
11. COMPANY PROFILES
11.1. THERMO FISHER SCIENTIFIC INC
11.1.1. COMPANY OVERVIEW
11.1.2. FINANCIAL OVERVIEW
11.1.3. TYPES OFFERED
11.1.4. KEY DEVELOPMENTS
11.1.5. SWOT ANALYSIS
11.1.6. KEY STRATEGIES
11.2. BIOLIFESOLUTIONS
11.3. LIFELINE SCIENTIFIC
11.4. BIOCISION, CESCA THERAPEUTICS, INC
11.5. CORE DYNAMICS GMBH
11.6. CUSTOM BIOGENIC SYSTEMS
11.7. ATLANTA BIOLOGICS PVT. LTD
11.8. TAYLOR-WHARTON
11.9. PANASONIC HOLDINGS CORPORATION
12. APPENDIX
12.1. REFERENCE REPORT
12.2. RELATED REPORTS
